Partnering with Novo Nordisk allows us to apply our platform across important metabolic disease areas, with the goal of enabling oral therapies that would otherwise require injection. Last month, Roche shared positive news on the advancement of its own injectable GLP-1/GIP receptor agonist candidate in obesity
A checklist of common side effects for retatrutide includes: Nausea Vomiting Diarrhea Constipation Stomach pain or discomfort Most of the trial participants experienced these stomach symptoms, and information regarding their severity or duration was not reported
While semaglutide tablets offer a promising path for weight loss, its essential to consider safety concerns, especially for individuals with a history of thyroid cancer or medullary thyroid carcinoma
Centers for Disease Control and Prevention.) Kennedy had previously expressed skepticism about GLP-1s, but he was full of praise for Trump for pushing to help a broader segment of Americans have access to the drug
Individuals with impaired kidney function may not be able to eliminate excess magnesium effectively, creating risk of accumulation